Rewriting Retail Reality: Engineering Smarter Data for Modern Enterprise
Solana (SOL) Price Prediction: Will SOL and Little Pepe (LILPEPE) Explode in 2025?
Artarium embraces sustainability with eco-friendly wooden tissue boxes
Gautam Adani takes BIG step, set to transform healthcare sector, to build 1000 AI-equipped...
UK's F-35 fighter jet stuck in Kerala to finally fly home next week? Reports claim...
IND vs ENG: Ravindra Jadeja throws open challenge to Joe Root on 99, dares him to complete run
What Should You Check Before Choosing a Cricket ID Provider on The Swamiji Online Platform?
Samsung confirms to launch tri-fold phones soon, eyes to unveil it by..., set to rival...
Donald Trump imposes 35% tariff on goods imported from Canada, plans up to 20% on remaining nations
World’s best sandwich, with unique recipe, made in this country, not US, UK, it’s from...
Govt plans to sell its stake in this Rs 586000 crore company, shares fall by...
Khalistani terrorist threatened Kapil Sharma before attack on his cafe, claims he ignored...
'It's not a holiday': Gautam Gambhir backs BCCI's diktat amidst Virat Kohli's viral outburst
'I'd love to work here': This company turns dry swimming pool into office space
Get the shaadi experience without getting Married: Welcome to 'fake wedding' parties
RCB pacer Yash Dayal makes new move after FIR lodged against him in sexual exploitation case
India's BIG statement on 500 per cent tariff threat from US, says, 'Halting trade with Russia...'
Trouble for Vikas Divyakirti? Court summons Drishti IAS founder for derogatory remarks against...
Will Shashi Tharoor be next Kerala CM? This is what survey says, Congress MP reacts
Mukesh Ambani-owned Reliance Industries Ltd falls sharply at BSE, is it due to delayed IPO of ...?
Two students stab principal to death after he asked for...; incident sparks fear in school
Anant Ambani, Radhika Merchant begin first wedding anniversary celebrations at Antilia, WATCH
Zero Se Restart: When and where to watch documentary on Vikrant Massey's 12th Fail
Can’t sleep more than 6 hours? You might have this rare sleep condition Short sleeper syndrome
Good news for Ratan Tata's TCS as its net profit rises to Rs....; market cap reaches Rs...
Tennis player Radhika Yadav shot dead by father, latter detained by police
Firing at Kapil Sharma's cafe in Canada, see SHOCKING video
Jasprit Bumrah teases ground officials after being warned to stay away from Lord's pitch
Indian-origin student pilot among two killed in mid-air plane crash in Canada
What is Lord's iconic tilt? Explaining the 2.5 meter slope and its game-changing effect on play
"Manoj Vishwakarma's Vision: DOTOM MV GROUP's Impact on Mumbai's Skyline"
How Prasanna Kumar Reddy Gurijala is Transforming Global Supply Chains: From Chaos to Clarity
The New Tech Powerhouse: How India became a global innovation engine
HEALTH
Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, Lyme disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications
Researchers have developed a new treatment method capable of detecting Lyme disease in just 15 minutes.
Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, Lyme disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications.
"Our findings are the first to demonstrate that Lyme disease diagnosis can be carried out in a microfluidic format that can provide rapid quantitative results," said Sam Sia, professor of biomedical engineering at Columbia Engineering.
"This means that our test could easily be used directly in a doctor's office, obviating having to send the samples out to a laboratory that needs at least a couple of hours, if not days, to get test results," added Sia whose lab is focused on using microfluidics to build low-cost, integrated devices for performing sophisticated medical tests, together with developing new treatment modalities based on cell therapy and implantable devices.
Sia's group worked in collaboration with Maria Gomes-Solecki from Immuno Technologies, which found a combination of three proteins that identified antibodies specific to the B. burgdorferi bacterium in the serum, and OPKO Health, which provided microfluidic cassettes. Their findings were published today in the journal of 'Clinical Microbiology'.
The researchers evaluated 142 samples, including patients with early Lyme disease, healthy individuals from areas where Lyme disease is endemic, and those with Lyme arthritis.
They first screened a set of known diagnostic Lyme disease biomarkers for their ability to detect Lyme disease infection. They then tested the top three biomarkers using a standard enzyme immunoassay, and then mChip-LD, an advanced microfluidic platform developed by Sam Sia, to test the samples.
When tested against additional samples of serum from people with Lyme disease, the multiplexed set of biomarkers was more sensitive than standard Lyme disease tests, while also exhibiting high specificity.
The team found that it was better at picking up signs of Lyme disease infection in early-stage samples -- possibly because it was able to detect antibodies that peak in the first weeks after someone is infected with Lyme disease.
When the test was run on Sia's mChip-LD platform, it worked very well, showing strong potential for the development of a point-of-care test for Lyme disease.
"While the assay will require more refinement and testing before it can be approved for widespread use as a test for Lyme disease, our results are very exciting," said one of the study's lead authors, Siddarth Arumugam, who is a PhD student in Sia's lab.
"It will help so many people if we can develop a single, rapid, multiplexed diagnostic test to identify Lyme disease stage that can be used in doctors' offices," added Siddarth Arumugam.